Evidence map›Paper›PMID 39789061›Full record

ArticleScientific reports2025

A collaborative network analysis for the interpretation of transcriptomics data in Huntington's disease.

Ozan Ozisik, Nazli Sila Kara, Tooba Abbassi-Daloii, Morgane Térézol, Elsa C Kuijper, Núria Queralt-Rosinach, Annika Jacobsen, Osman Ugur Sezerman, Marco Roos, Chris T Evelo and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ozan OzisikAix Marseille Univ, INSERM, MMG, Marseille, France. ozan.ozisik@inserm.fr.
Nazli Sila KaraInstitute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Tooba Abbassi-DaloiiDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Morgane TérézolAix Marseille Univ, INSERM, MMG, Marseille, France.
Elsa C KuijperDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Núria Queralt-RosinachDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Annika JacobsenDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Osman Ugur SezermanDepartment of Biostatistics and Medical Informatics, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Marco RoosDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Chris T EveloDepartment of Bioinformatics-BiGCaT, NUTRIM/MHeNs, Maastricht University, Maastricht, The Netherlands.
Anaïs BaudotAix Marseille Univ, INSERM, MMG, Marseille, France.
Friederike EhrhartDepartment of Bioinformatics-BiGCaT, NUTRIM/MHeNs, Maastricht University, Maastricht, The Netherlands.
Eleni MinaDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Funding

Horizon 2020 EJP RD COFUND-EJP N° 825575
6 · The paper itself

Abstract

Rare diseases may affect the quality of life of patients and be life-threatening. Therapeutic opportunities are often limited, in part because of the lack of understanding of the molecular mechanisms underlying these diseases. This can be ascribed to the low prevalence of rare diseases and therefore the lower sample sizes available for research. A way to overcome this is to integrate experimental rare disease data with prior knowledge using network-based methods. Taking this one step further, we hypothesized that combining and analyzing the results from multiple network-based methods could provide data-driven hypotheses of pathogenic mechanisms from multiple perspectives.We analyzed a Huntington's disease transcriptomics dataset using six network-based methods in a collaborative way. These methods either inherently reported enriched annotation terms or their results were fed into enrichment analyses. The resulting significantly enriched Reactome pathways were then summarized using the ontological hierarchy which allowed the integration and interpretation of outputs from multiple methods. Among the resulting enriched pathways, there are pathways that have been shown previously to be involved in Huntington's disease and pathways whose direct contribution to disease pathogenesis remains unclear and requires further investigation.In summary, our study shows that collaborative network analysis approaches are well-suited to study rare diseases, as they provide hypotheses for pathogenic mechanisms from multiple perspectives. Applying different methods to the same case study can uncover different disease mechanisms that would not be apparent with the application of a single method.

Indexed as

Gene Expression ProfilingHuntington DiseaseTranscriptomeComputational BiologyGene Regulatory NetworksHumansCollaborative analysisHuntington’s diseaseNetwork analysisRare disease

Identifiers

PMID39789061
PMCPMC11718016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.